Research advances in the study of sleep disorders, circadian rhythm disturbances and Alzheimer’s disease
Authors:
Open Access
- 17 August 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 14, 944283
Abstract
Although there are still no satisfactory answers to the question of why we need to sleep, a better understanding of its function will help to improve societal attitudes toward sleep. Sleep disorders are very common in neurodegenerative diseases and are a key factor in the quality of life of patients and their families. Alzheimer’s disease (AD) is an insidious and irreversible neurodegenerative disease. Along with progressive cognitive impairment, sleep disorders and disturbances in circadian rhythms play a key role in the progression of AD. Sleep and circadian rhythm disturbances are more common in patients with AD than in the general population and can appear early in the course of the disease. Therefore, this review discusses the bidirectional relationships among circadian rhythm disturbances, sleep disorders, and AD. In addition, pharmacological and non-pharmacological treatment options for patients with AD and sleep disorders are outlined.Keywords
This publication has 135 references indexed in Scilit:
- Aberrant light directly impairs mood and learning through melanopsin-expressing neuronsNature, 2012
- Efficacy of Brief Behavioral Treatment for Chronic Insomnia in Older AdultsArchives of internal medicine (1960), 2011
- Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older womenAnnals of Neurology, 2011
- Racial/Ethnic Disparities in Exercise and Dietary Behaviors of Middle-Aged and Older AdultsJournal of General Internal Medicine, 2010
- Association of Plasma Clusterin Concentration With Severity, Pathology, and Progression in Alzheimer DiseaseArchives of General Psychiatry, 2010
- Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer diseaseNeurobiology of Aging, 2009
- Melatonin Fails to Improve Sleep or Agitation in Double-Blind Randomized Placebo-Controlled Trial of Institutionalized Patients With Alzheimer DiseaseThe American Journal of Geriatric Psychiatry, 2009
- The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer diseaseNature Genetics, 2007
- A Drosophila model for age-associated changes in sleep:wake cyclesProceedings of the National Academy of Sciences, 2006
- Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's diseaseNature, 1991